Search

Your search keyword '"Horak F"' showing total 1,115 results
Start Over Author "Horak F"
1,115 results on '"Horak F"'

2. Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD.

Author

Kangarloo, T., Latzman, R. D., Adams, J. L., Dorsey, R., Kostrzebski, M., Severson, J., Anderson, D., Horak, F., Stephenson, D., and Cosman, J.

Subjects
PARKINSON'S disease diagnosis, DIGITAL technology, T-test (Statistics), STATISTICAL significance, RESEARCH funding, DIGITAL health, SCIENTIFIC observation, QUESTIONNAIRES, WEARABLE technology, HOME environment, DESCRIPTIVE statistics, LONGITUDINAL method, DATA analysis software, DISEASE progression
Abstract

Introduction: Digital health technologies (DHTs) have the potential to alleviate challenges experienced in clinical trials through more objective, naturalistic, and frequent assessments of functioning. However, implementation of DHTs come with their own challenges, including acceptability and ease of use for study participants. In addition to acceptability, it is also important to understand device proficiency in the general population and within patient populations who may be asked to use DHTs for extended periods of time. We thus aimed to provide an overview of participant feedback on acceptability of DHTs, including body-worn sensors used in the clinic and a mobile application used at-home, used throughout the duration of the Wearable Assessments in the Clinic and at Home in Parkinson's Disease (WATCH-PD) study, an observational, longitudinal study looking at disease progression in early Parkinson's Disease (PD). Methods: 82 participants with PD and 50 control participants were enrolled at 17 sites throughout the United States and followed for 12 months. We assessed participants' general device proficiency at baseline, using the Mobile Device Proficiency Questionnaire (MDPQ). The mean MDPQ score at Baseline did not significantly differ between PD patients and healthy controls (20.6 [2.91] vs 21.5 [2.94], p = .10). Results: Questionnaire results demonstrated that participants had generally positive views on the comfort and use of the digital technologies throughout the duration of the study, regardless of group. Discussion: This is the first study to evaluate patient feedback and impressions of using technology in a longitudinal observational study in early Parkinson's Disease. Results demonstrate device proficiency and acceptability of various DHTs in people with Parkinson's does not differ from that of neurologically healthy older adults, and, overall, participants had a favorable view of the DHTs deployed in the WATCH-PD study. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. On the trajectory of discrimination: A meta-analysis and forecasting survey capturing 44 years of field experiments on gender and hiring decisions

Author

Schaerer, M, Plessis, C, Nguyen, M, Aert, R, Tiokhin, L, Lakens, D, Clemente, E, Pfeiffer, T, Dreber, A, Johannesson, M, Clark, C, Uhlmann, E, Abraham, A, Adamus, M, Akinci, C, Alberti, F, Alsharawy, A, Alzahawi, S, Anseel, F, Arndt, F, Balkan, B, Baskin, E, Bearden, C, Benotsch, E, Bernritter, S, Black, S, Bleidorn, W, Boysen, A, Brienza, J, Brown, M, Brown, S, Brown, J, Buckley, J, Buttliere, B, Byrd, N, Cigler, H, Capitan, T, Cherubini, P, Chong, S, Ciftci, E, Conrad, C, Conway, P, Costa, E, Cox, J, Cox, D, Cruz, F, Dawson, I, Demiral, E, Derrick, J, Doshi, S, Dunleavy, D, Durham, J, Elbaek, C, Ellis, D, Ert, E, Espinoza, M, Fullbrunn, S, Fath, S, Furrer, R, Fiala, L, Fillon, A, Forsgren, M, Fytraki, A, Galarza, F, Gandhi, L, Garrison, S, Geraldes, D, Ghasemi, O, Gjoneska, B, Gothilander, J, Gruhn, D, Grieder, M, Hafenbradl, S, Halkias, G, Hancock, R, Hantula, D, Harton, H, Hoffmann, C, Holzmeister, F, Horak, F, Hosch, A, Imada, H, Ioannidis, K, Jaeger, B, Janas, M, Janik, B, Kc, R, Keel, P, Keeley, J, Keller, L, Kenrick, D, Kiely, K, Knutsson, M, Kovacheva, A, Kovera, M, Krivoshchekov, V, Krumrei-Mancuso, E, Kulibert, D, Lacko, D, Lemay, E, Leung, D, Li, F, Lin, H, Lorenzo, K, Lorenzo-Luaces, L, Lou, N, Lovakov, A, Luzardo, A, Macaulay, S, Madan, C, Mahmoud, O, Makel, M, Mari, S, Fages, D, Marsh, A, Mccarthy, R, Mercier, B, Milfont, T, Mittlaender, S, Montoya, A, Moyer, A, Myrseth, K, Navarro-Martinez, D, Nelson, A, Neyse, L, Minghui, N, Niszczota, P, Obrecht, N, Otterbring, T, Panlilio, Z, Park, L, Pauer, S, Pavlov, Y, Pentek, I, Pereyra, J, Perkowski, P, Pew, E, Peynircioglu, Z, Pezzo, M, Pirrone, A, Plonsky, O, Porfirio, J, Pownall, M, Prochnicki, M, Protzko, J, Roer, J, Rahnev, D, Reis, H, Rios, K, Rodrigues, D, Rodriguez, P, Roth, Y, Ruffle, B, Samahita, M, Schmidt, A, Schoemann, M, Schoenegger, P, Schwebel, D, Segovia, A, Sherman, J, Siegenthaler, S, Siem, B, Sirota, M, Smith, E, Stamatogiannakis, A, Stewart-Williams, S, Storage, D, Su, Y, Talbert, E, Todd, A, Tonin, M, Trautmann, S, Travaglino, G, Tsang, J, Veldhuizen, R, Varnum, M, Walf, A, Wallrich, L, Wang, K, Ward, D, Waugh, C, Wingen, T, Woike, J, Wollbrant, C, Wu, S, Wylie, K, Xiao, Q, Xue, S, Yakobi, O, Zayas, V, Zheng, J, Zhong, Y, Zogmaister, C, Zolopa, C, Lisa, N, Chin Wen, O, Dmitry, G, Schaerer M., Plessis C. D., Nguyen M. H. B., Aert R. C. M. V., Tiokhin L., Lakens D., Clemente E. G., Pfeiffer T., Dreber A., Johannesson M., Clark C. J., Uhlmann E. L., Abraham A. T., Adamus M., Akinci C., Alberti F., Alsharawy A. M., Alzahawi S., Anseel F., Arndt F., Balkan B., Baskin E., Bearden C. E., Benotsch E. G., Bernritter S., Black S. R., Bleidorn W., Boysen A. P., Brienza J. P., Brown M., Brown S. E. V., Brown J. W., Buckley J., Buttliere B., Byrd N., Cigler H., Capitan T., Cherubini P., Chong S. Y., Ciftci E. E., Conrad C. D., Conway P., Costa E., Cox J. A., Cox D. J., Cruz F., Dawson I. G. J., Demiral E. E., Derrick J. L., Doshi S., Dunleavy D. J., Durham J. D., Elbaek C. T., Ellis D. A., Ert E., Espinoza M. P., Fullbrunn S. C., Fath S., Furrer R., Fiala L., Fillon A. A., Forsgren M., Fytraki A. T., Galarza F. B., Gandhi L., Garrison S. M., Geraldes D., Ghasemi O., Gjoneska B., Gothilander J., Gruhn D., Grieder M., Hafenbradl S., Halkias G., Hancock R., Hantula D. A., Harton H. C., Hoffmann C. P., Holzmeister F., Horak F., Hosch A. -K., Imada H., Ioannidis K., Jaeger B., Janas M., Janik B., Kc R. P., Keel P. K., Keeley J. W., Keller L., Kenrick D. T., Kiely K. M., Knutsson M., Kovacheva A., Kovera M. B., Krivoshchekov V., Krumrei-Mancuso E. J., Kulibert D., Lacko D., Lemay E. P., Leung D. W., Li F., Lin H., Lorenzo K. E., Lorenzo-Luaces L., Lou N. M., Lovakov A., Luzardo A., MacAulay S. C., Madan C. R., Mahmoud O., Makel M. C., Mari S., Fages D. M., Marsh A. A., McCarthy R. J., Mercier B., Milfont T. L., Mittlaender S., Montoya A. K., Moyer A., Myrseth K. O. R., Navarro-Martinez D., Nelson A. J., Neyse L., Minghui N., Niszczota P., Obrecht N. A., Otterbring T., Panlilio Z. A., Park L. E., Pauer S., Pavlov Y. G., Pentek I., Pereyra J. S., Perkowski P., Pew E., Peynircioglu Z. F., Pezzo M. V., Pirrone A., Plonsky O., Porfirio J. C. C., Pownall M., Prochnicki M. M., Protzko J., Roer J. P., Rahnev D., Reis H. T., Rios K., Rodrigues D. L., Rodriguez P., Roth Y., Ruffle B. J., Samahita M., Schmidt A., Schoemann M., Schoenegger P., Schwebel D. C., Segovia A. M., Sherman J. W., Siegenthaler S., Siem B., Sirota M., Smith E. R., Stamatogiannakis A., Stewart-Williams S., Storage D., Su Y., Talbert E. J., Todd A. R., Tonin M., Trautmann S. T., Travaglino G. A., Tsang J. -A., Veldhuizen R. V., Varnum M. E. W., Walf A. A., Wallrich L., Wang K., Ward D. E., Waugh C. E., Wingen T., Woike J. K., Wollbrant C. E., Wu S., Wylie K., Xiao Q., Xue S. Y., Yakobi O., Zayas V., Zheng J., Zhong Y., Zogmaister C., Zolopa C. S., Lisa N., Chin Wen O., Dmitry G., Schaerer, M, Plessis, C, Nguyen, M, Aert, R, Tiokhin, L, Lakens, D, Clemente, E, Pfeiffer, T, Dreber, A, Johannesson, M, Clark, C, Uhlmann, E, Abraham, A, Adamus, M, Akinci, C, Alberti, F, Alsharawy, A, Alzahawi, S, Anseel, F, Arndt, F, Balkan, B, Baskin, E, Bearden, C, Benotsch, E, Bernritter, S, Black, S, Bleidorn, W, Boysen, A, Brienza, J, Brown, M, Brown, S, Brown, J, Buckley, J, Buttliere, B, Byrd, N, Cigler, H, Capitan, T, Cherubini, P, Chong, S, Ciftci, E, Conrad, C, Conway, P, Costa, E, Cox, J, Cox, D, Cruz, F, Dawson, I, Demiral, E, Derrick, J, Doshi, S, Dunleavy, D, Durham, J, Elbaek, C, Ellis, D, Ert, E, Espinoza, M, Fullbrunn, S, Fath, S, Furrer, R, Fiala, L, Fillon, A, Forsgren, M, Fytraki, A, Galarza, F, Gandhi, L, Garrison, S, Geraldes, D, Ghasemi, O, Gjoneska, B, Gothilander, J, Gruhn, D, Grieder, M, Hafenbradl, S, Halkias, G, Hancock, R, Hantula, D, Harton, H, Hoffmann, C, Holzmeister, F, Horak, F, Hosch, A, Imada, H, Ioannidis, K, Jaeger, B, Janas, M, Janik, B, Kc, R, Keel, P, Keeley, J, Keller, L, Kenrick, D, Kiely, K, Knutsson, M, Kovacheva, A, Kovera, M, Krivoshchekov, V, Krumrei-Mancuso, E, Kulibert, D, Lacko, D, Lemay, E, Leung, D, Li, F, Lin, H, Lorenzo, K, Lorenzo-Luaces, L, Lou, N, Lovakov, A, Luzardo, A, Macaulay, S, Madan, C, Mahmoud, O, Makel, M, Mari, S, Fages, D, Marsh, A, Mccarthy, R, Mercier, B, Milfont, T, Mittlaender, S, Montoya, A, Moyer, A, Myrseth, K, Navarro-Martinez, D, Nelson, A, Neyse, L, Minghui, N, Niszczota, P, Obrecht, N, Otterbring, T, Panlilio, Z, Park, L, Pauer, S, Pavlov, Y, Pentek, I, Pereyra, J, Perkowski, P, Pew, E, Peynircioglu, Z, Pezzo, M, Pirrone, A, Plonsky, O, Porfirio, J, Pownall, M, Prochnicki, M, Protzko, J, Roer, J, Rahnev, D, Reis, H, Rios, K, Rodrigues, D, Rodriguez, P, Roth, Y, Ruffle, B, Samahita, M, Schmidt, A, Schoemann, M, Schoenegger, P, Schwebel, D, Segovia, A, Sherman, J, Siegenthaler, S, Siem, B, Sirota, M, Smith, E, Stamatogiannakis, A, Stewart-Williams, S, Storage, D, Su, Y, Talbert, E, Todd, A, Tonin, M, Trautmann, S, Travaglino, G, Tsang, J, Veldhuizen, R, Varnum, M, Walf, A, Wallrich, L, Wang, K, Ward, D, Waugh, C, Wingen, T, Woike, J, Wollbrant, C, Wu, S, Wylie, K, Xiao, Q, Xue, S, Yakobi, O, Zayas, V, Zheng, J, Zhong, Y, Zogmaister, C, Zolopa, C, Lisa, N, Chin Wen, O, Dmitry, G, Schaerer M., Plessis C. D., Nguyen M. H. B., Aert R. C. M. V., Tiokhin L., Lakens D., Clemente E. G., Pfeiffer T., Dreber A., Johannesson M., Clark C. J., Uhlmann E. L., Abraham A. T., Adamus M., Akinci C., Alberti F., Alsharawy A. M., Alzahawi S., Anseel F., Arndt F., Balkan B., Baskin E., Bearden C. E., Benotsch E. G., Bernritter S., Black S. R., Bleidorn W., Boysen A. P., Brienza J. P., Brown M., Brown S. E. V., Brown J. W., Buckley J., Buttliere B., Byrd N., Cigler H., Capitan T., Cherubini P., Chong S. Y., Ciftci E. E., Conrad C. D., Conway P., Costa E., Cox J. A., Cox D. J., Cruz F., Dawson I. G. J., Demiral E. E., Derrick J. L., Doshi S., Dunleavy D. J., Durham J. D., Elbaek C. T., Ellis D. A., Ert E., Espinoza M. P., Fullbrunn S. C., Fath S., Furrer R., Fiala L., Fillon A. A., Forsgren M., Fytraki A. T., Galarza F. B., Gandhi L., Garrison S. M., Geraldes D., Ghasemi O., Gjoneska B., Gothilander J., Gruhn D., Grieder M., Hafenbradl S., Halkias G., Hancock R., Hantula D. A., Harton H. C., Hoffmann C. P., Holzmeister F., Horak F., Hosch A. -K., Imada H., Ioannidis K., Jaeger B., Janas M., Janik B., Kc R. P., Keel P. K., Keeley J. W., Keller L., Kenrick D. T., Kiely K. M., Knutsson M., Kovacheva A., Kovera M. B., Krivoshchekov V., Krumrei-Mancuso E. J., Kulibert D., Lacko D., Lemay E. P., Leung D. W., Li F., Lin H., Lorenzo K. E., Lorenzo-Luaces L., Lou N. M., Lovakov A., Luzardo A., MacAulay S. C., Madan C. R., Mahmoud O., Makel M. C., Mari S., Fages D. M., Marsh A. A., McCarthy R. J., Mercier B., Milfont T. L., Mittlaender S., Montoya A. K., Moyer A., Myrseth K. O. R., Navarro-Martinez D., Nelson A. J., Neyse L., Minghui N., Niszczota P., Obrecht N. A., Otterbring T., Panlilio Z. A., Park L. E., Pauer S., Pavlov Y. G., Pentek I., Pereyra J. S., Perkowski P., Pew E., Peynircioglu Z. F., Pezzo M. V., Pirrone A., Plonsky O., Porfirio J. C. C., Pownall M., Prochnicki M. M., Protzko J., Roer J. P., Rahnev D., Reis H. T., Rios K., Rodrigues D. L., Rodriguez P., Roth Y., Ruffle B. J., Samahita M., Schmidt A., Schoemann M., Schoenegger P., Schwebel D. C., Segovia A. M., Sherman J. W., Siegenthaler S., Siem B., Sirota M., Smith E. R., Stamatogiannakis A., Stewart-Williams S., Storage D., Su Y., Talbert E. J., Todd A. R., Tonin M., Trautmann S. T., Travaglino G. A., Tsang J. -A., Veldhuizen R. V., Varnum M. E. W., Walf A. A., Wallrich L., Wang K., Ward D. E., Waugh C. E., Wingen T., Woike J. K., Wollbrant C. E., Wu S., Wylie K., Xiao Q., Xue S. Y., Yakobi O., Zayas V., Zheng J., Zhong Y., Zogmaister C., Zolopa C. S., Lisa N., Chin Wen O., and Dmitry G.

Abstract

A preregistered meta-analysis, including 244 effect sizes from 85 field audits and 361,645 individual job applications, tested for gender bias in hiring practices in female-stereotypical and gender-balanced as well as male-stereotypical jobs from 1976 to 2020. A “red team” of independent experts was recruited to increase the rigor and robustness of our meta-analytic approach. A forecasting survey further examined whether laypeople (n = 499 nationally representative adults) and scientists (n = 312) could predict the results. Forecasters correctly anticipated reductions in discrimination against female candidates over time. However, both scientists and laypeople overestimated the continuation of bias against female candidates. Instead, selection bias in favor of male over female candidates was eliminated and, if anything, slightly reversed in sign starting in 2009 for mixed-gender and male-stereotypical jobs in our sample. Forecasters further failed to anticipate that discrimination against male candidates for stereotypically female jobs would remain stable across the decades.

Published
2023

6. Lungenfunktionsdiagnostik

Author

Fuchs, S., Fuchs, O., Riedler, J., Horak, F., Zacharasiewicz, A., Barker, M., von Mutius, Erika, editor, Gappa, Monika, editor, Eber, Ernst, editor, and Frey, Urs, editor

Published
2013
Full Text
View/download PDF

7. S3 guideline Allergy Prevention

Author

Kopp, M., V, Muche-Borowski, C., Abou-Dakn, M., Ahrens, B., Beyer, K., Blumchen, K., Bubel, P., Chaker, A., Cremer, M., Ensenauer, R., Gerstlauer, M., Gieler, U., Hubner, I. M., Horak, F., Klimek, L., Koletzko, B., V, Koletzko, S., Lau, S., Lob-Corzilius, T., Nemat, K., Peters, E. M. J., Pizzulli, A., Reese, I, Rolinck-Werninghaus, C., Rouw, E., Schaub, B., Schmidt, S., Steiss, J. O., Striegel, A. K., Szepfalusi, Z., Schlembach, D., Spindler, T., Taube, C., Trendelenburg, V, Treudler, R., Umpfenbach, U., Vogelberg, C., Wagenmann, M., Weissenborn, A., Werfel, T., Worm, M., Sitter, H., Hamelmann, E., Kopp, M., V, Muche-Borowski, C., Abou-Dakn, M., Ahrens, B., Beyer, K., Blumchen, K., Bubel, P., Chaker, A., Cremer, M., Ensenauer, R., Gerstlauer, M., Gieler, U., Hubner, I. M., Horak, F., Klimek, L., Koletzko, B., V, Koletzko, S., Lau, S., Lob-Corzilius, T., Nemat, K., Peters, E. M. J., Pizzulli, A., Reese, I, Rolinck-Werninghaus, C., Rouw, E., Schaub, B., Schmidt, S., Steiss, J. O., Striegel, A. K., Szepfalusi, Z., Schlembach, D., Spindler, T., Taube, C., Trendelenburg, V, Treudler, R., Umpfenbach, U., Vogelberg, C., Wagenmann, M., Weissenborn, A., Werfel, T., Worm, M., Sitter, H., and Hamelmann, E.

Abstract

Background: The persistently high prevalence of allergic diseases in Western industrial nations and the limited possibilities of causal therapy make evidence-based recommendations for primary prevention necessary. Methods: The recommendations of the S3 guideline Allergy Prevention, published in its last version in 2014, were revised and consulted on the basis of a current systematic literature search. The evidence search was conducted for the period 06/2013 - 11/2020 in the electronic databases Cochrane and MEDLINE, as well as in the reference lists of current reviews and through references from experts. The literature found was screened in two filtering processes, first by title and abstract, and the remaining papers were screened in the full text for relevance. The studies included after this were sorted by level of evidence, and the study quality was indicated in terms of potential bias (low/high). The revised recommendations were formally agreed and consented upon with the participation of representatives of the relevant professional societies and (self-help) organizations (nominal group process). Of 5,681 hits, 286 studies were included and assessed. Results: Recommendations on maternal nutrition during pregnancy and breastfeeding as well as on infant nutrition in the first months of life again play an important role in the updated guideline: Many of the previous recommendations were confirmed by the current data. It was specified that breastfeeding should be exclusive for the first 4 - 6 months after birth, if possible, and that breastfeeding should continue with the introduction of complementary foods. A new recommendation is that supplementary feeding of cow's milk-based formula should be avoided in the first days of life if the mother wishes to breastfeed. Furthermore, it was determined that the evidence for a clear recommendation for hydrolyzed infant formula in non-breastfed infants at risk is currently no longer sufficient. It is therefore currently reco

Published
2022

8. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

Author

Hellings, P. W., Fokkens, W. J., Bachert, C., Akdis, C. A., Bieber, T., Agache, I., Bernal‐Sprekelsen, M., Canonica, G. W., Gevaert, P., Joos, G., Lund, V., Muraro, A., Onerci, M., Zuberbier, T., Pugin, B., Seys, S. F., Bousquet, J., Aberer, W, Agache, I, Akdis, CA, Akdis, M, Alobid, I, Ankri, J, Annesi‐Maesano, I, Ansotegui, IJ, Anto, JM, Arnavielhe, S, Arshad, H, Asarnoj, A, Avolio, F, Bachert, C, Bachert, C, Baiardini, I, Barbagallo, M, Barbara, C, Baroody, F, Bateman, ED, Bedbrook, A, Beghé, B, Bel, EH, Bennoor, KS, Benson, M, Bergmann, KC, Bewick, M, Bialoszewski, AZ, Bieber, T, Bindslev‐Jensen, C, Bjermer, L, Blain, H, Blasi, F, Boner, AL, Bonini, M, Bonini, S, Bosnic‐Anticevich, S, Bosse, I, Bouchard, J, Boulet, LP, Bourret, R, Bousquet, J, Bousquet, PJ, Braido, F, Briggs, AH, Brightling, CE, Brozek, J, Bucca, C, Buhl, R, Bunu, C, Burte, E, Bush, A, Caballero‐Fonseca, F, Caimmi, DP, Calderon, MA, Camargos, PA, Camuzat, T, Canonica, GW, Cardona, V, Carlsen, KH, Carr, W, Carreiro‐Martins, P, Carriazo, AM, Casale, T, Cepeda Sarabia, AM, Cervin, A, Cesari, M, Chatzi, L, Chavannes, NH, Chiron, R, Chivato, T, Chkhartishvili, E, Chuchalin, AG, Chung, KF, Ciprandi, G, Cohen, N, Conzález Diaz, S, Cox, L, Crooks, G, Cruz, AA, Custovic, A, Dahl, R, Dahlen, SE, Darsow, U, De Carlo, G, De Manuel Keenoy, E, de Sousa, JC, De Vries, G, Dedeu, T, Deleanu, D, Demoly, P, Denburg, JA, Devillier, P, Didier, A, Dinh‐Xuan, AT, Dokic, D, Douagui, H, Douglas, R, Dray, G, Du Toit, G, Dubakiene, R, Durham, SR, Dykewicz, MS, Eklund, P, El‐Gamal, Y, Ellers, E, Emuzyte, R, Farrell, J, Fink Wagner, A, Fiocchi, A, Fletcher, M, Fokkens, WJ, Fonseca, J, Forastiere, F, Gaga, M, Gamkrelidze, A, Gemicioğlu, B, Georgalas, C, Gereda, JE, Gevaert, P, Goossens, H, Grisle, I, Guldemond, NA, Gutter, Z, Guzmán, MA, Haahtela, T, Harvey, R, Heinrich, J, Hellings, PW, Hellings, PW, Hellquist‐Dahl, B, Hopkins, C, Horak, F, Hourihane, JO, Humbert, M, Hyland, M, Iaccarino, G, Illario, M, Jares, EJ, Jeandel, C, Johnston, SL, Jonquet, O, Joos, G, Joos, G, Jung, KS, Just, J, Jutel, M, Kaidashev, I, Kalayci, O, Kalogjera, L, Kalyoncu, AF, Kardas, P, Keil, T, Keith, PK, Kerkhof, M, Kern, B, Kerstjens, HA, Khaitov, M, Khaltaev, N, Klimek, L, Kogevinas, M, Kolek, V, Koppelman, GH, Kowalski, M, Kowalski, ML, Kuitunen, M, Kull, I, Kuna, P, Kvedariene, V, Lambrecht, B, Larenas‐Linnemann, D, Lau, S, Laune, D, Le, LT, Li, J, Lieberman, P, Lipworth, B, Lodrup Carlsen, KC, Louis, R, Lund, VJ, Lupinek, C, MacNee, W, Magar, Y, Magnan, A, Mahboub, B, Maier, D, Majer, I, Malva, J, Manning, P, Marshall, GD, Masjedi, MR, Mathieu‐Dupas, E, Maurer, M, Mavale‐Manuel, S, Melén, E, Melo‐Gomes, E, Meltzer, EO, Mercier, J, Merk, H, Miculinic, N, Mihaltan, F, Milenkovic, B, Millot‐Keurinck, J, Mohammad, Y, Momas, I, Morais‐Almeida, M, Mösges, R, Mullol, J, Mullol, J, Muraro, A, Murray, R, Naclerio, R, Nadif, R, Namazova‐Baranova, L, Neffen, H, Nekam, K, Nieto, A, Niggemann, B, Nogueira‐Silva, L, Nogues, M, Nyembue, TD, OʼHehir, RE, Ohta, K, Okamoto, Y, Okubo, K, Olive‐Elias, M, Ouedraogo, S, Paggiaro, P, Pali‐Schöll, I, Palkonen, S, Panzner, P, Papadopoulos, NG, Papi, A, Park, HS, Passalacqua, G, Pawankar, R, Pedersen, S, Pereira, AM, Pfaar, O, Picard, R, Pigearias, B, Pin, I, Plavec, D, Pohl, W, Popov, TA, Portejoie, F, Postma, D, Potter, P, Poulsen, LK, Price, D, Price, D, Rabe, KF, Raciborski, F, Riechelmann, H, Robalo‐Cordeiro, C, Roberts, G, Rodenas, F, Rodriguez‐Mañas, L, Rolland, C, Roman Rodriguez, M, Romano, A, Rosado‐Pinto, J, Rosario, N, Rottem, M, Ryan, D, Samolinski, B, Sanchez‐Borges, M, Sastre‐Dominguez, J, Scadding, GK, Schlosser, R, Schmid‐Grendelmeier, P, Schunemann, HJ, Scichilone, N, Senior, B, Serrano, E, Sheikh, A, Shields, M, Simons, FER, Siroux, V, Sisul, JC, Skrindo, I, Smit, HA, Solé, D, Sooronbaev, T, Spranger, O, Stellato, C, Stelmach, R, Sterk, PJ, Strandberg, T, Sunyer, J, Thijs, C, Thomas, M, Todo‐Bom, A, Tomazic, PV, Toskala, E, Triggiani, M, Valenta, R, Valero, A, Valiulis, A, Valovirta, E, van Eerd, M, van Ganse, E, van Hage, M, van Wick, RG, Vandenplas, O, Varona, LL, Vazankari, T, Vellas, B, Ventura, MT, Vezzani, G, Viegi, G, Voegels, R, Vontetsianos, T, Wagenmann, M, Wahn, U, Walker, S, Wang, DY, Wang, Y, Werfel, T, Whalley, B, Wickman, M, Williams, DM, Williams, S, Wilson, N, Wormald, PJ, Wright, J, Yawn, BP, Yiallouros, PK, Yorgancioglu, A, Young, I, Yusuf, OM, Zaidi, A, Zar, HJ, Zernotti, ME, Zhang, L, Zhong, N, Zidarn, M, and Zuberbier, T

Published
2017
Full Text
View/download PDF

10. S3-Leitlinie Allergieprävention

Author

Kopp, M.V., primary, Muche-Borowski, C., additional, Abou-Dakn, M., additional, Ahrens, B., additional, Beyer, K., additional, Blümchen, K., additional, Bubel, P., additional, Chaker, A., additional, Cremer, M., additional, Ensenauer, R., additional, Gerstlauer, M., additional, Gieler, U., additional, Hübner, I.M., additional, Horak, F., additional, Klimek, L., additional, Koletzko, B.V., additional, Koletzko, S., additional, Lau, S., additional, Lob-Corzilius, T., additional, Nemat, K., additional, Peters, E.M.J., additional, Pizzulli, A., additional, Reese, I., additional, Rolinck-Werninghaus, C., additional, Rouw, E., additional, Schaub, B., additional, Schmidt, S., additional, Steiß, J.O., additional, Striegel, A.K., additional, Szépfalusi, Z., additional, Schlembach, D., additional, Spindler, T., additional, Taube, C., additional, Trendelenburg, V., additional, Treudler, R., additional, Umpfenbach, U., additional, Vogelberg, C., additional, Wagenmann, M., additional, Weißenborn, A., additional, Werfel, T., additional, Worm, M., additional, Sitter, H., additional, and Hamelmann, E., additional

Published
2022
Full Text
View/download PDF

11. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

Author

Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I., Bavbek, S., Bossios, A., Casper, I., Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szépfalusi, Z., Pohl, W., Hötzenecker, W., Rosenkranz, A. R., Bergmann, K. C., Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mösges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, K. F., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Mülleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P. V., Aberer, W., Fink-Wagner, A. H., Horak, F., Wöhrl, S., Niederberger-Leppin, V., Pali-Schöll, I., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J. P., Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., O'Mahony, L., Knol, E. F., del Giacco, S., Chivato Pérez, T., Bousquet, J., Zuberbier, T., Akdis, C., and Jutel, M.

Subjects
Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Omalizumab, Dupilumab, Immunoglobulin E, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Reslizumab, Immunology and Allergy, Medicine, 030223 otorhinolaryngology, Mepolizumab, biology, SARS-CoV-2, business.industry, Benralizumab, Telemedicine, 030228 respiratory system, chemistry, Immunology, biology.protein, Covid-19, business, medicine.drug
Published
2020

12. S3-Leitlinie Allergieprävention

Author

Kopp, Matthias V., Muche-Borowski, C., Abou-Dakn, M., Ahrens, B., Beyer, K., Blümchen, K., Bubel, P., Chaker, A., Cremer, M., Ensenauer, R., Gerstlauer, M., Gieler, U., Hübner, I.M., Horak, F., Klimek, L., Koletzko, B.V., Koletzko, S., Lau, S., Lob-Corzilius, T., Nemat, K., Peters, E.M.J., Pizzulli, A., Reese, I., Rolinck-Werninghaus, C., Rouw, E., Schaub, B., Schmidt, S., Steiß, J.O., Striegel, A.K., Szépfalusi, Z., Schlembach, D., Spindler, T., Taube, Christian, Trendelenburg, V., Treudler, R., Umpfenbach, U., Vogelberg, C., Wagenmann, M., Weißenborn, A., Werfel, T., Worm, M., Sitter, H., Hamelmann, Eckard, Hübner, Inga-Marie, Koletzko, Berthold V., Peters, Eva M.J., Steiß, Jens-Oliver, and Striegel, Anne Kathrin

Subjects
Medizin
Abstract

Hintergrund: Die anhaltend hohe Prävalenz allergischer Erkrankungen in westlichen Industrienationen und die eingeschränkten Möglichkeiten einer kausalen Therapie machen eine evidenzbasierte Primärprävention notwendig. Methoden: Die Empfehlungen der in letzter Fassung 2014 veröffentlichten S3-Leitlinie Allergieprävention wurden auf der Basis einer aktuellen systematischen Literatursuche überarbeitet und konsentiert. Die Evidenzsuche erfolgte für den Zeitraum 06/2013 – 11/2020 in den elektronischen Datenbanken Cochrane und MEDLINE, sowie in den Referenzlisten von aktuellen Übersichtsarbeiten und durch Hinweise von Experten. Die aufgefundene Literatur wurde in zwei Filterprozessen zunächst nach Titel und Zusammenfassung und die verbliebenen Arbeiten im Volltext auf Relevanz hin überprüft. Die danach eingeschlossenen Studien wurden nach Evidenzgrade geordnet und die Studienqualität i.S. des Verzerrungspotenzials (niedrig/hoch) angegeben. Die überarbeiteten Empfehlungen wurden unter Beteiligung von Vertretern der relevanten Fachgesellschaften und (Selbsthilfe-)Organisationen formal abgestimmt und konsentiert (nominaler Gruppenprozess). Von 5.681 Treffern wurden 286 Studien eingeschlossen und bewertet. Ergebnisse: Einen wichtigen Stellenwert in der aktualisierten Leitlinie nehmen wieder Empfehlungen zur Ernährung der Mutter während der Schwangerschaft und Stillzeit sowie des Säuglings in den ersten Lebensmonaten ein: Dabei wurden viele der bisherigen Empfehlungen durch die aktuelle Datenlage bestätigt. Präzisiert wurde, dass für den Zeitraum der ersten 4 – 6 Monate nach Geburt nach Möglichkeit ausschließlich gestillt werden soll und auch mit Einführung von Beikost weitergestillt werden soll. Neu ist die Empfehlung, dass eine Zufütterung von kuhmilchbasierter Formulanahrung in den ersten Lebenstagen bei Stillwunsch der Mutter vermieden werden sollte. Ferner wurde festgestellt, dass die Evidenz für eine klare positive Empfehlung für hydrolysierte Säuglingsnahrung bei nicht gestillten Risikokindern aktuell nicht mehr ausreicht. Aktuell wird daher empfohlen zu prüfen, ob bis zur Einführung von Beikost eine Säuglingsanfangsnahrung mit in Studien zur Allergieprävention nachgewiesener Wirksamkeit verfügbar ist. Schließlich wurden auf Basis der EAACI-Leitlinie zur Prävention der Hühnereiallergie die Empfehlung ausgesprochen, durcherhitztes (zum Beispiel verbackenes oder hartgekochtes), aber nicht „rohes“ Hühnerei (auch kein Rührei) mit der Beikost einzuführen und regelmäßig weiter zu geben. Die Empfehlung zur Einführung von Erdnuss in der Beikost wurde für den deutschsprachigen Raum zurückhaltend formuliert: In Familien mit bereits bestehendem regelmäßigem Erdnusskonsum kann zur Prävention einer Erdnussallergie bei Säuglingen mit atopischer Dermatitis die regelmäßige Gabe von erdnusshaltigen Nahrungsmitteln in altersgerechter Form (zum Beispiel Erdnussbutter) mit der Beikost erwogen werden. Vor der Einführung muss insbesondere bei Säuglingen mit moderater bis schwerer AD eine klinisch relevante Erdnussallergie ausgeschlossen werden. Für eine allergiepräventive Wirksamkeit von Präbiotika oder Probiotika, Vitamin D oder anderen Vitaminen in Form von Präparaten fehlt weiterhin ausreichende Evidenz, sodass in der aktuellen Leitlinie erstmals Empfehlungen gegen deren Supplementierung verabschiedet wurden. Die Biodiversität spielt für die Entwicklung einer immunologischen Toleranz gegenüber Umwelt- und Nahrungsmittelallergenen eine wichtige Rolle: So gibt es deutliche Hinweise darauf, dass das Aufwachsen auf dem Bauernhof mit einem geringeren Risiko für die Entwicklung von Asthma und allergischen Erkrankungen assoziiert ist. Dies wird mit einer frühzeitigen unspezifischen Immunstimulation unter anderem durch die größere mikrobielle Biodiversität des Hausstaubs in diesem Lebensraum in Verbindung gebracht. Dieser Aspekt spiegelt sich auch in den Empfehlungen zur Tierhaltung wider, zu der eine differenzierte Stellungnahme erfolgte: In Familien ohne erkennbares erhöhtes Allergierisiko soll die Haustierhaltung mit Katzen oder Hunden nicht generell eingeschränkt werden. Familien mit erhöhtem Allergierisiko (d. h. Vater, Mutter oder Geschwisterkind sind von einer atopischen Erkrankung betroffen) oder bei Kindern mit bereits bestehender atopischer Dermatitis sollten eine Katze nicht neu anschaffen – im Gegensatz dazu sollte von einer Hundehaltung jedoch nicht abgeraten werden. Interventionen zur Reduktion der Exposition gegenüber Hausstaubmilbenallergenen im Haushalt, zum Beispiel die Verwendung milbenallergendichter Matratzenüberzüge („encasings“), sollten nicht mit dem Ziel einer primären Allergieprävention erfolgen. Kinder, die durch einen Kaiserschnitt geboren wurden, haben ein geringfügig erhöhtes Asthmarisiko – dies soll bei der Beratung zum Geburtsmodus außerhalb von Notfallsituationen berücksichtigt werden. Auch aktuelle Arbeiten stützen die Empfehlungen zu Luftschadstoffen: Die aktive und passive Exposition gegenüber Tabakrauch erhöhen das Allergierisiko und sind deshalb zu vermeiden. Die Exposition gegenüber Stickoxiden, Ozon und Feinstaub der Partikelgröße < 2,5 Mikrometer (PM 2,5) ist mit einem erhöhten Risiko, besonders für Asthma, verbunden. Daher sollte die Exposition gegenüber Emissionen gegenüber Stickoxiden, Ozon und Feinstaub (PM 2,5) gering gehalten werden. Die Autor/-innen dieser Leitlinie sprechen sich einhellig für den Erlass entsprechender Verordnungen zur Minimierung dieser Luftschadstoffe aus. Es gibt keine Belege, dass Impfungen das Allergierisiko erhöhen, umgekehrt aber Hinweise, dass Impfungen das Allergierisiko senken können. Alle Kinder, auch Risikokinder, sollen auch aus Gründen der Allergieprävention nach den aktuellen Empfehlungen der ­STIKO geimpft werden. Schlussfolgerung: Die Konsentierung von Empfehlungen in dieser Leitlinie beruht auf einer umfangreichen Evidenzgrundlage. Die Aktualisierung der Leitlinie ermöglicht evidenzbasierte und aktuelle Empfehlungen zur Prävention allergischer Erkrankungen.

Published
2022

13. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Author

Bousquet, J., Hellings, P. W., Agache, I., Bedbrook, A., Bachert, C., Bergmann, K. C., Bewick, M., Bindslev-Jensen, C., Bosnic-Anticevitch, S., Bucca, C., Caimmi, D. P., Camargos, P. A. M., Canonica, G. W., Casale, T., Chavannes, N. H., Cruz, A. A., De Carlo, G., Dahl, R., Demoly, P., Devillier, P., Fonseca, J., Fokkens, W. J., Guldemond, N. A., Haahtela, T., Illario, M., Just, J., Keil, T., Klimek, L., Kuna, P., Larenas-Linnemann, D., Morais-Almeida, M., Mullol, J., Murray, R., Naclerio, R., O’Hehir, R. E., Papadopoulos, N. G., Pawankar, R., Potter, P., Ryan, D., Samolinski, B., Schunemann, H. J., Sheikh, A., Simons, F. E. R., Stellato, C., Todo-Bom, A., Tomazic, P. V., Valiulis, A., Valovirta, E., Ventura, M. T., Wickman, M., Young, I., Yorgancioglu, A., Zuberbier, T., Aberer, W., Akdis, C. A., Akdis, M., Annesi-Maesano, I., Ankri, J., Ansotegui, I. J., Anto, J. M., Arnavielhe, S., Asarnoj, A., Arshad, H., Avolio, F., Baiardini, I., Barbara, C., Barbagallo, M., Bateman, E. D., Beghé, B., Bel, E. H., Bennoor, K. S., Benson, M., Białoszewski, A. Z., Bieber, T., Bjermer, L., Blain, H., Blasi, F., Boner, A. L., Bonini, M., Bonini, S., Bosse, I., Bouchard, J., Boulet, L. P., Bourret, R., Bousquet, P. J., Braido, F., Briggs, A. H., Brightling, C. E., Brozek, J., Buhl, R., Bunu, C., Burte, E., Bush, A., Caballero-Fonseca, F., Calderon, M. A., Camuzat, T., Cardona, V., Carreiro-Martins, P., Carriazo, A. M., Carlsen, K. H., Carr, W., Cepeda Sarabia, A. M., Cesari, M., Chatzi, L., Chiron, R., Chivato, T., Chkhartishvili, E., Chuchalin, A. G., Chung, K. F., Ciprandi, G., de Sousa, J. Correia, Cox, L., Crooks, G., Custovic, A., Dahlen, S. E., Darsow, U., Dedeu, T., Deleanu, D., Denburg, J. A., De Vries, G., Didier, A., Dinh-Xuan, A. T., Dokic, D., Douagui, H., Dray, G., Dubakiene, R., Durham, S. R., Du Toit, G., Dykewicz, M. S., Eklund, P., El-Gamal, Y., Ellers, E., Emuzyte, R., Farrell, J., Fink Wagner, A., Fiocchi, A., Fletcher, M., Forastiere, F., Gaga, M., Gamkrelidze, A., Gemicioğlu, B., Gereda, J. E., van Wick, R. Gerth, González Diaz, S., Grisle, I., Grouse, L., Gutter, Z., Guzmán, M. A., Hellquist-Dahl, B., Heinrich, J., Horak, F., Hourihane, J. O’. B., Humbert, M., Hyland, M., Iaccarino, G., Jares, E. J., Jeandel, C., Johnston, S. L., Joos, G., Jonquet, O., Jung, K. S., Jutel, M., Kaidashev, I., Khaitov, M., Kalayci, O., Kalyoncu, A. F., Kardas, P., Keith, P. K., Kerkhof, M., Kerstjens, H. A. M., Khaltaev, N., Kogevinas, M., Kolek, V., Koppelman, G. H., Kowalski, M. L., Kuitunen, M., Kull, I., Kvedariene, V., Lambrecht, B., Lau, S., Laune, D., Le, L. T. T., Lieberman, P., Lipworth, B., Li, J., Lodrup Carlsen, K. C., Louis, R., Lupinek, C., MacNee, W., Magar, Y., Magnan, A., Mahboub, B., Maier, D., Majer, I., Malva, J., Manning, P., De Manuel Keenoy, E., Marshall, G. D., Masjedi, M. R., Mathieu-Dupas, E., Maurer, M., Mavale-Manuel, S., Melén, E., Melo-Gomes, E., Meltzer, E. O., Mercier, J., Merk, H., Miculinic, N., Mihaltan, F., Milenkovic, B., Millot-Keurinck, J., Mohammad, Y., Momas, I., Mösges, R., Muraro, A., Namazova-Baranova, L., Nadif, R., Neffen, H., Nekam, K., Nieto, A., Niggemann, B., Nogueira-Silva, L., Nogues, M., Nyembue, T. D., Ohta, K., Okamoto, Y., Okubo, K., Olive-Elias, M., Ouedraogo, S., Paggiaro, P., Pali-Schöll, I., Palkonen, S., Panzner, P., Papi, A., Park, H. S., Passalacqua, G., Pedersen, S., Pereira, A. M., Pfaar, O., Picard, R., Pigearias, B., Pin, I., Plavec, D., Pohl, W., Popov, T. A., Portejoie, F., Postma, D., Poulsen, L. K., Price, D., Rabe, K. F., Raciborski, F., Roberts, G., Robalo-Cordeiro, C., Rodenas, F., Rodriguez-Mañas, L., Rolland, C., Roman Rodriguez, M., Romano, A., Rosado-Pinto, J., Rosario, N., Rottem, M., Sanchez-Borges, M., Sastre-Dominguez, J., Scadding, G. K., Scichilone, N., Schmid-Grendelmeier, P., Serrano, E., Shields, M., Siroux, V., Sisul, J. C., Skrindo, I., Smit, H. A., Solé, D., Sooronbaev, T., Spranger, O., Stelmach, R., Sterk, P. J., Strandberg, T., Sunyer, J., Thijs, C., Triggiani, M., Valenta, R., Valero, A., van Eerd, M., van Ganse, E., van Hague, M., Vandenplas, O., Varona, L. L., Vellas, B., Vezzani, G., Vazankari, T., Viegi, G., Vontetsianos, T., Wagenmann, M., Walker, S., Wang, D. Y., Wahn, U., Werfel, T., Whalley, B., Williams, D. M., Williams, S., Wilson, N., Wright, J., Yawn, B. P., Yiallouros, P. K., Yusuf, O. M., Zaidi, A., Zar, H. J., Zernotti, M. E., Zhang, L., Zhong, N., and Zidarn, M.

Published
2016
Full Text
View/download PDF

17. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

Author

Bousquet, J., Schunemann, H. J., Fonseca, J., Samolinski, B., Bachert, C., Canonica, G. W., Casale, T., Cruz, A. A., Demoly, P., Hellings, P., Valiulis, A., Wickman, M., Zuberbier, T., Bosnic-Anticevitch, S., Bedbrook, A., Bergmann, K. C., Caimmi, D., Dahl, R., Fokkens, W. J., Grisle, I., Carlsen, Lodrup K., Mullol, J., Muraro, A., Palkonen, S., Papadopoulos, N., Passalacqua, G., Ryan, D., Valovirta, E., Yorgancioglu, A., Aberer, W., Agache, I., Adachi, M., Akdis, C. A., Akdis, M., Annesi-Maesano, I., Ansotegui, I. J., Anto, J. M., Arnavielhe, S., Arshad, H., Baiardini, I., Baigenzhin, A. K., Barbara, C., Bateman, E. D., Beghé, B., Bel, E. H., Ben Kheder, A., Bennoor, K. S., Benson, M., Bewick, M., Bieber, T., Bindslev-Jensen, C., Bjermer, L., Blain, H., Boner, A. L., Boulet, L. P., Bonini, M., Bonini, S., Bosse, I., Bourret, R., Bousquet, P. J., Braido, F., Briggs, A. H., Brightling, C. E., Brozek, J., Buhl, R., Burney, P. G., Bush, A., Caballero-Fonseca, F., Calderon, M. A., Camargos, P. A. M., Camuzat, T., Carlsen, K. H., Carr, W., Cepeda Sarabia, A. M., Chavannes, N. H., Chatzi, L., Chen, Y. Z., Chiron, R., Chkhartishvili, E., Chuchalin, A. G., Ciprandi, G., Cirule, I., de Sousa, Correia J., Cox, L., Crooks, G., Costa, D. J., Custovic, A., Dahlen, S. E., Darsow, U., De Carlo, G., De Blay, F., Dedeu, T., Deleanu, D., Denburg, J. A., Devillier, P., Didier, A., Dinh-Xuan, A. T., Dokic, D., Douagui, H., Dray, G., Dubakiene, R., Durham, S. R., Dykewicz, M. S., El-Gamal, Y., Emuzyte, R., Wagner, Fink A., Fletcher, M., Fiocchi, A., Forastiere, F., Gamkrelidze, A., Gemicioğlu, B., Gereda, J. E., Diaz, González S., Gotua, M., Grouse, L., Guzmán, M. A., Haahtela, T., Hellquist-Dahl, B., Heinrich, J., Horak, F., Hourihane, J. O.‘B., Howarth, P., Humbert, M., Hyland, M. E., Ivancevich, J. C., Jares, E. J., Johnston, S. L., Joos, G., Jonquet, O., Jung, K. S., Just, J., Kaidashev, I., Kalayci, O., Kalyoncu, A. F., Keil, T., Keith, P. K., Khaltaev, N., Klimek, L., NʼGoran, Koffi B., Kolek, V., Koppelman, G. H., Kowalski, M. L., Kull, I., Kuna, P., Kvedariene, V., Lambrecht, B., Lau, S., Larenas-Linnemann, D., Laune, D., Le, L. T. T., Lieberman, P., Lipworth, B., Li, J., Louis, R., Magard, Y., Magnan, A., Mahboub, B., Majer, I., Makela, M. J., Manning, P., De Manuel Keenoy, E., Marshall, G. D., Masjedi, M. R., Maurer, M., Mavale-Manuel, S., Melén, E., Melo-Gomes, E., Meltzer, E. O., Merk, H., Miculinic, N., Mihaltan, F., Milenkovic, B., Mohammad, Y., Molimard, M., Momas, I., Montilla-Santana, A., Morais-Almeida, M., Mösges, R., Namazova-Baranova, L., Naclerio, R., Neou, A., Neffen, H., Nekam, K., Niggemann, B., Nyembue, T. D., OʼHehir, R. E., Ohta, K., Okamoto, Y., Okubo, K., Ouedraogo, S., Paggiaro, P., Pali-Schöll, I., Palmer, S., Panzner, P., Papi, A., Park, H. S., Pavord, I., Pawankar, R., Pfaar, O., Picard, R., Pigearias, B., Pin, I., Plavec, D., Pohl, W., Popov, T. A., Portejoie, F., Postma, D., Potter, P., Price, D., Rabe, K. F., Raciborski, F., Pontal, Radier F., Repka-Ramirez, S., Robalo-Cordeiro, C., Rolland, C., Rosado-Pinto, J., Reitamo, S., Rodenas, F., Rodriguez, Roman M., Romano, A., Rosario, N., Rosenwasser, L., Rottem, M., Sanchez-Borges, M., Scadding, G. K., Serrano, E., Schmid-Grendelmeier, P., Sheikh, A., Simons, F. E. R., Sisul, J. C., Skrindo, I., Smit, H. A., Solé, D., Sooronbaev, T., Spranger, O., Stelmach, R., Strandberg, T., Sunyer, J., Thijs, C., Todo-Bom, A., Triggiani, M., Valenta, R., Valero, A. L., van Hage, M., Vandenplas, O., Vezzani, G., Vichyanond, P., Viegi, G., Wagenmann, M., Walker, S., Wang, D. Y., Wahn, U., Williams, D. M., Wright, J., Yawn, B. P., Yiallouros, P. K., Yusuf, O. M., Zar, H. J., Zernotti, M. E., Zhang, L., Zhong, N., Zidarn, M., and Mercier, J.

Published
2015
Full Text
View/download PDF

20. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma - Addendum 2020 : herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. und der Deutschen Atemwegsliga e.V., unter Beteiligung der Gesellschaft für Pädiatrische Pneumologie e.V. und der Österreichischen Gesellschaft für Pneumologie

Author

Buhl, R., Bals, R., Baur, X., Berdel, D., Criée, C.-P., Gappa, M., Gillissen, A., Greulich, T., Haidl, P., Hamelmann, E., Horak, F., Kardos, P., Kenn, K., Klimek, L., Korn, S., Magnussen, H., Nowak, D., Pfaar, O., Rabe, K.F., Riedler, J., Ritz, T., Schultz, K., Schuster, A., Spindler, T., Taube, Christian, Vogelmeier, C., Von Leupoldt, A., Wantke, F., Wildhaber, J., Worth, H., Zacharasiewicz, A., and Lommatzsch, M.

Subjects
Adult, Adolescent, immune system diseases, Austria, Medizin, Pulmonary Medicine, Humans, Child, Asthma, Societies, Medical, respiratory tract diseases
Abstract

The present addendum of the guideline for the diagnosis and treatment of asthma (2017) complements new insights into the diagnosis and management of asthma as well as for the newly approved drugs for the treatment of asthma. Current, evidence-based recommendations on diagnostic and therapeutic approaches are presented for children and adolescents as well as for adults with asthma.Das vorliegende Addendum zur Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma (2017) ergänzt wichtige neue Erkenntnisse zur Diagnostik und Therapie von Asthma sowie zu neu für die Therapie des Asthmas zugelassenen Medikamenten. Es werden sowohl für Kinder und Jugendliche als auch für Erwachsene mit Asthma die aktuellen, Evidenz-basierten diagnostischen und therapeutischen Empfehlungen dargelegt.

Published
2021

22. TURN-IT: a novel turning intervention program to improve quality of turning in daily life in people with Parkinson's disease.

Author

King, LA, Carlson-Kuhta, P, Wilhelm, JL, Lapidus, JA, Dale, ML, Talman, LS, Barlow, N, Mancini, M, Horak, FB, King, L A, Wilhelm, J L, Lapidus, J A, Dale, M L, Talman, L S, and Horak, F B

Subjects
PARKINSON'S disease, EVERYDAY life, MEDICAL rehabilitation, WEARABLE technology, EVALUATION research, RESEARCH funding, GAIT in humans, RANDOMIZED controlled trials, RESEARCH, COMPARATIVE studies
Abstract

Background: People with Parkinson's disease (PD) have a high fall rate and many falls are associated with turns. Despite this, there is minimal research on effects of rehabilitation on the quality of turns. Further, quantifying turns in the home may have broader implications since rehabilitation of turns would ideally improve turning in real world mobility.Methods: Sixty people with PD and a history of falls will be randomized to receive either a novel TURNing InTervention (TURN-IT) or no intervention (control group). The TURN-IT group will be seen for 6 weeks (18 visits) for an individualized, progressive program that is based on the specific constraints of turning in PD. Wearable sensors will be used to measure 7 days of mobility, including turns, before and after intervention or control period. In addition, blinded assessments of gait, mobility and turns will occur before and after intervention for both groups and falls will be monitored for twelve months post intervention with bimonthly email questionnaires.Discussion: This study has the potential to change how we rehabilitate and assess turning in people with PD and falls. There are several novel aspects to our study including a comprehensive turning-focused intervention that is tailored to the underlying constraints that impair turning in people with PD. Further, our outcome measure of turning quality during 7 days of daily life is novel and has implications for determining real-life changes after rehabilitation. The ultimate goal of this rehabilitation intervention is to improve how patients turn in daily life and to reduce falls.Trials Registration: This protocol is registered at clinicaltrials.gov; #NCT04897256; https://clinicaltrials.gov/ct2/show/NCT04897256?term=Horak&cond=Parkinson+Disease&draw=2&rank=4 . [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

23. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma – Addendum 2020

Author

Buhl, R, Bals, R, Baur, X, Berdel, D, Criee, C-P, Gappa, M, Gillissen, A, Greulich, T, Haidl, P, Hamelmann, Eckard, Horak, F, Kardos, P, Kenn, K, Klimek, L, Korn, S, Magnussen, H, Nowak, D, Pfaar, O, Rabe, K F, Riedler, J, Ritz, T, Schultz, K, Schuster, A, Spindler, T, Taube, C, Vogelmeier, C, von Leupoldt, A, Wantke, F, Wildhaber, J, Worth, H, Zacharasiewicz, A, and Lommatzsch, M

Subjects
immune system diseases, respiratory tract diseases
Abstract

The present addendum of the guideline for the diagnosis and treatment of asthma (2017) complements new insights into the diagnosis and management of asthma as well as for the newly approved drugs for the treatment of asthma. Current, evidence-based recommendations on diagnostic and therapeutic approaches are presented for children and adolescents as well as for adults with asthma. Thieme. All rights reserved.

Published
2021

24. Peanut���induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry

Author

Maris, Ioana, D��lle���Bierke, Sabine, Renaudin, Jean���Marie, Lange, Lars, Koehli, Alice, Spindler, Thomas, Hourihane, Jonathan, Scherer, Kathrin, Nemat, Katja, Kemen, C., Neust��dter, Irena, Vogelberg, Christian, Reese, Thomas, Yildiz, Ismail, Szepfalusi, Zsolt, Ott, Hagen, Straube, Helen, Papadopoulos, Nikolaos G., H��mmerling, Susanne, Staden, Ute, Polz, Michael, Mustakov, Tihomir, Cichocka���Jarosz, Ewa, Cocco, Renata, Fiocchi, Alessandro Giovanni, Fernandez���Rivas, Montserrat, Worm, Margitta, Gr��nhagen, J, Wittenberg, M, Beyer, K, Henschel, A, K��per, S, M��ser, A, Fuchs, T, Ru��ff, F, Wedi, B, Hansen, G, Buck, T, B��sselberg, J, Dr��gerdt, R, Pfeffer, L, Dickel, H, K��rner���Rettberg, C, Merk, H, Lehmann, S, Bauer, A, Nordwig, A, Zeil, S, Hannapp, C, Wagner, N, Rietschel, E, Hunzelmann, N, Huseynow, I, Treudler, R, Aurich, S, Prenzel, F, Klimek, L, Pfaar, O, Reider, N, Aberer, W, Varga, E, Bogatu, B, Schmid���Grendelmeier, P, Guggenheim, R, Riffelmann, F, Kreft, B, Kinaciyan, K, Hartl, L, Ebner, C, Horak, F, Brehler, R, Witte, J, Buss, M, Hompes, S, Bieber, T, Gernert, S, B��cheler, M, Rabe, U, Brosi, W, Nestoris, S, Hawranek, T, Lang, R, Bruns, R, Pf��hler, C, Eng, P, Schweitzer���Krantz, S, Meller, S, Rebmann, H, Fischer, J, Stichtenoth, G, Thies, S, Gerstlauer, M, Utz, P, Neust��dter, I, Klinge, J, Volkmuth, S, Plank���Habibi, S, Schilling, B, Kleinheinz, A, Br��ckner, A, Sch��kel, K, Manolaraki, I, Kowalski, M, Solarewicz���Madajek, K, Tscheiller, S, Seidenberg, J, Cardona, V, Garcia, B, Bilo, M, Caba��es Higuero, N, Vega Castro, A, Poziomkowska���G��sicka, I, B��sing, S, Virchow, C, Christoff, G, Jappe, U, M��ller, S, Kn��pfel, F, Correard, A���K, Rogala, B, Montoro, A, Brandes, A, Muraro, A, Zimmermann, N, Hernandez, D, Minale, P, Niederwimmer, J, Zahel, B, Dahdah, L, Arasi, S, Reissig, A, Eitelberger, F, Asero, R, Hermann, F, Zeidler, S, Pistauer, S, Gei��ler, M, Ensina, L, Plaza Martin, A, Meister, J, Stieglitz, S, Hamelmann, E, and Network For Online Registration Of Anaphylaxis (NORA)

Subjects
0301 basic medicine, Allergy, medicine.medical_specialty, Adolescent, Arachis, Epinephrine, Immunology, Peanut allergy, Peanut-induced anaphylaxis, paediatrics, 03 medical and health sciences, 0302 clinical medicine, Food allergy, Internal medicine, medicine, anaphylaxis, Humans, Immunology and Allergy, Peanut Hypersensitivity, In patient, Registries, Child, Asthma, food allergy, business.industry, food and beverages, medicine.disease, Comorbidity, 030104 developmental biology, 030228 respiratory system, business, Anaphylaxis, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
Abstract

Background Peanut allergy has a rising prevalence in high-income countries, affecting 0.5%-1.4% of children. This study aimed to better understand peanut anaphylaxis in comparison to anaphylaxis to other food triggers in European children and adolescents. Methods Data was sourced from the European Anaphylaxis Registry via an online questionnaire, after in-depth review of food-induced anaphylaxis cases in a tertiary paediatric allergy centre. Results 3514 cases of food anaphylaxis were reported between July 2007 - March 2018, 56% in patients younger than 18 years. Peanut anaphylaxis was recorded in 459 children and adolescents (85% of all peanut anaphylaxis cases). Previous reactions (42% vs. 38%; p = .001), asthma comorbidity (47% vs. 35%; p < .001), relevant cofactors (29% vs. 22%; p = .004) and biphasic reactions (10% vs. 4%; p = .001) were more commonly reported in peanut anaphylaxis. Most cases were labelled as severe anaphylaxis (Ring&Messmer grade III 65% vs. 56% and grade IV 1.1% vs. 0.9%; p = .001). Self-administration of intramuscular adrenaline was low (17% vs. 15%), professional adrenaline administration was higher in non-peanut food anaphylaxis (34% vs. 26%; p = .003). Hospitalization was higher for peanut anaphylaxis (67% vs. 54%; p = .004). Conclusions The European Anaphylaxis Registry data confirmed peanut as one of the major causes of severe, potentially life-threatening allergic reactions in European children, with some characteristic features e.g., presence of asthma comorbidity and increased rate of biphasic reactions. Usage of intramuscular adrenaline as first-line treatment is low and needs to be improved. The Registry, designed as the largest database on anaphylaxis, allows continuous assessment of this condition.

Published
2021
Full Text
View/download PDF

34. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie : Ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion)

Author

Pfaar, O., Klimek, L., Worm, M., Bergmann, K.-C., Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mösges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Mülleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P.-V., Aberer, W., Fink-Wagner, A., Horak, F., Wöhrl, S., Niederberger-Leppin, V., Pali-Schöll, I., Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertini, F., Khaltaev, N., Michel, J.-P., Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, Christian, Gerstlauer, M., Vogelberg, C., Bousquet, J., and Zuberbier, T.

Subjects
Betacoronavirus, Desensitization, Immunologic, SARS-CoV-2, Pneumonia, Viral, Medizin, COVID-19, Humans, Coronavirus Infections, Pandemics
Published
2020

35. Stellungnahme der Österreichischen Gesellschaft für Pneumologie (ÖGP)

Author

Flick, H., Arns, B. M., Bolitschek, J., Bucher, B., Cima, K., Gingrich, E., Handzhiev, S., Hochmair, M., Horak, F., Idzko, M., Jaksch, P., Kovacs, G., Kropfmüller, R., Lamprecht, B., Löffler-Ragg, J., Meilinger, M., Olschewski, H., Pfleger, A., Puchner, B., Puelacher, C., Prior, C., Rodriguez, P., Salzer, H., Schenk, P., Schindler, O., Stelzmüller, I., Strenger, V., Täubl, H., Urban, M., Wagner, M., Wimberger, F., Zacharasiewicz, A., Zwick, R. H., and Eber, E.

Published
2020
Full Text
View/download PDF

36. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B<

Author

Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I., Bavbek, S., Bossios, A., Casper, I., Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szépfalusi, Z., Pohl, W., Hötzenecker, W., Rosenkranz, A.R., Bergmann, K.C., Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mösges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, K.F., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Mülleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P.V., Aberer, W., Fink-Wagner, A.H., Horak, F., Wöhrl, S., Niederberger-Leppin, V., Pali-Schöll, I., Roller-Wirnsberger, R., Spranger, O., Akdis, M., Matricardi, P.M., Spertini, F., Khaltaev, N., Michel, J.P., Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., O Mahony, L., Knol, E.F., Del Giacco, S., Chivato Pérez, T., Bedbrook, A., Zuberbier, T., Akdis, C., and Jutel, M.

Subjects
Covid-19, Sars-cov-2, Benralizumab, Dupilumab, Mepolizumab, Omalizumab, Reslizumab, Telemedicine
Abstract

BACKGROUND: Since the beginning of the COVID-19 pandemic, the treatment of patients with allergic and atopy-associated diseases has faced major challenges. Recommendations for "social distancing" and the fear of patients becoming infected during a visit to a medical facility have led to a drastic decrease in personal doctor-patient contacts. This affects both acute care and treatment of the chronically ill. The immune response after SARS-CoV-2 infection is so far only insufficiently understood and could be altered in a favorable or unfavorable way by therapy with monoclonal antibodies. There is currently no evidence for an increased risk of a severe COVID-19 course in allergic patients. Many patients are under ongoing therapy with biologicals that inhibit type 2 immune responses via various mechanisms. There is uncertainty about possible immunological interactions and potential risks of these biologicals in the case of an infection with SARS-CoV-2. MATERIALS AND METHODS: A selective literature search was carried out in PubMed, Livivo, and the internet to cover the past 10 years (May 2010 - April 2020). Additionally, the current German-language publications were analyzed. Based on these data, the present position paper provides recommendations for the biological treatment of patients with allergic and atopy-associated diseases during the COVID-19 pandemic. RESULTS: In order to maintain in-office consultation services, a safe treatment environment must be created that is adapted to the pandemic situation. To date, there is a lack of reliable study data on the care for patients with complex respiratory, atopic, and allergic diseases in times of an imminent infection risk from SARS-CoV-2. Type-2-dominant immune reactions, as they are frequently seen in allergic patients, could influence various phases of COVID-19, e.g., by slowing down the immune reactions. Theoretically, this could have an unfavorable effect in the early phase of a SARS-Cov-2 infection, but also a positive effect during a cytokine storm in the later phase of severe courses. However, since there is currently no evidence for this, all data from patients treated with a biological directed against type 2 immune reactions who develop COVID-19 should be collected in registries, and their disease courses documented in order to be able to provide experience-based instructions in the future. CONCLUSION: The use of biologicals for the treatment of bronchial asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, and spontaneous urticaria should be continued as usual in patients without suspected infection or proven SARS-CoV-2 infection. If available, it is recommended to prefer a formulation for self-application and to offer telemedical monitoring. Treatment should aim at the best possible control of difficult-to-control allergic and atopic diseases using adequate rescue and add-on therapy and should avoid the need for systemic glucocorticosteroids. If SARS-CoV-2 infection is proven or reasonably suspected, the therapy should be determined by weighing the benefits and risks individually for the patient in question, and the patient should be involved in the decision-making. It should be kept in mind that the potential effects of biologicals on the immune response in COVID-19 are currently not known. Telemedical offers are particularly desirable for the acute consultation needs of suitable patients.

Published
2020

37. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic [Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie]

Author

Klimek, L. Pfaar, O. Worm, M. Eiwegger, T. Hagemann, J. Ollert, M. Untersmayr, E. Hoffmann-Sommergruber, K. Vultaggio, A. Agache, I. Bavbek, S. Bossios, A. Casper, I. Chan, S. Chatzipetrou, A. Vogelberg, C. Firinu, D. Kauppi, P. Kolios, A. Kothari, A. Matucci, A. Palomares, O. Szépfalusi, Z. Pohl, W. Hötzenecker, W. Rosenkranz, A.R. Bergmann, K.-C. Bieber, T. Buhl, R. Buters, J. Darsow, U. Keil, T. Kleine-Tebbe, J. Lau, S. Maurer, M. Merk, H. Mösges, R. Saloga, J. Staubach, P. Jappe, U. Rabe, K.F. Rabe, U. Vogelmeier, C. Biedermann, T. Jung, K. Schlenter, W. Ring, J. Chaker, A. Wehrmann, W. Becker, S. Freudelsperger, L. Mülleneisen, N. Nemat, K. Czech, W. Wrede, H. Brehler, R. Fuchs, T. Tomazic, P.-V. Aberer, W. Fink-Wagner, A.-H. Horak, F. Wöhrl, S. Niederberger-Leppin, V. Pali-Schöll, I. Pohl, W. Roller-Wirnsberger, R. Spranger, O. Valenta, R. Akdis, M. Matricardi, P.M. Spertini, F. Khaltaev, N. Michel, J.-P. Nicod, L. Schmid-Grendelmeier, P. Idzko, M. Hamelmann, E. Jakob, T. Werfel, T. Wagenmann, M. Taube, C. Jensen-Jarolim, E. Korn, S. Hentges, F. Schwarze, J. O'Mahony, L. Knol, E.F. del Giacco, S. Chivato Pérez, T. Bousquet, J. Zuberbier, T. Akdis, C. Jutel, M. Positionspapier des arzteverbands Deutscher Allergologen (AeDA) der Deutschen Gesellschaft fur Allergologie und klinische Immunologie (DGAKI) der Gesellschaft fur Padiatrische Allergologie und Umweltmedizin (GPA) der osterreichischen Gesellschaft fur Allergologie und Immunologie (oGAI) der Luxemburgischen Gesellschaft fur Allergologie und Immunologie (LGAI) der osterreichischen Gesellschaft fur Pneumologie (oGP) Kooperation mit der deutschen, osterreichischen, und schweizerischen ARIA-Gruppe der Europaischen Akademie fur Allergologie und Klinische Immunologie (EAACI)

Published
2020

39. Allergen immuntherapy in the current COVID-19 pandemic - A position paper of ARIA, EAACI, AeDA, DGAKI, and GPA

Author

Klimek, L., Pfaar, O., Worm, M., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Bousquet, J., Zuberbier, T., Vogelberg, C., Gerstlauer, M., Klimek, L., Pfaar, O., Worm, M., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Bousquet, J., Zuberbier, T., Vogelberg, C., and Gerstlauer, M.

Published
2020

40. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID 19 pandemic

Author

Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I, Bavbek, S., Bossios, A., Casper, I, Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szepfalusi, Z., Pohl, W., Hoetzenecker, W., Rosenkranz, A., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, C., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., OMahony, L., Knol, E., del Giacco, S., Chivato Perez, T., Bousquet, J., Zuberbier, T., Akdis, C., Jutel, M., Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I, Bavbek, S., Bossios, A., Casper, I, Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szepfalusi, Z., Pohl, W., Hoetzenecker, W., Rosenkranz, A., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, C., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., OMahony, L., Knol, E., del Giacco, S., Chivato Perez, T., Bousquet, J., Zuberbier, T., Akdis, C., and Jutel, M.

Published
2020

41. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA- EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)

Author

Pfaar, O., Klimek, L., Worm, M., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mosges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Gerstlauer, M., Vogelberg, C., Bousquet, J., Zuberbier, T., Pfaar, O., Klimek, L., Worm, M., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mosges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Gerstlauer, M., Vogelberg, C., Bousquet, J., and Zuberbier, T.

Published
2020

47. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Author

Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., Canonica, G. W., Casale, T. B., Cruz, A. A., Fokkens, W. J., Fonseca, J. A., van Wijk, Gerth R., Grouse, L., Haahtela, T., Khaltaev, N., Kuna, P., Lockey, R. F., Lodrup Carlsen, K. C., Mullol, J., Naclerio, R., OʼHehir, R. E., Ohta, K., Palkonen, S., Papadopoulos, N. G., Passalacqua, G., Pawankar, R., Price, D., Ryan, D., Simons, F. E.R., Togias, A., Williams, D., Yorgancioglu, A., Yusuf, O. M., Aberer, W., Adachi, M., Agache, I., Aït-Khaled, N., Akdis, C. A., Andrianarisoa, A., Annesi-Maesano, I., Ansotegui, I. J., Baiardini, I., Bateman, E. D., Bedbrook, A., Beghé, B., Beji, M., Bel, E. H., Ben Kheder, A., Bennoor, K. S., Bergmann, K. C., Berrissoul, F., Bieber, T., Bindslev Jensen, C., Blaiss, M. S., Boner, A. L., Bouchard, J., Braido, F., Brightling, C. E., Bush, A., Caballero, F., Calderon, M. A., Calvo, M. A., Camargos, P. A.M., Caraballo, L. R., Carlsen, K. H., Carr, W., Cepeda, A. M., Cesario, A., Chavannes, N. H., Chen, Y. Z., Chiriac, A. M., Chivato Pérez, T., Chkhartishvili, E., Ciprandi, G., Costa, D. J., Cox, L., Custovic, A., Dahl, R., Darsow, U., De Blay, F., Deleanu, D., Denburg, J. A., Devillier, P., Didi, T., Dokic, D., Dolen, W. K., Douagui, H., Dubakiene, R., Durham, S. R., Dykewicz, M. S., El-Gamal, Y., El-Meziane, A., Emuzyte, R., Fiocchi, A., Fletcher, M., Fukuda, T., Gamkrelidze, A., Gereda, J. E., González Diaz, S., Gotua, M., Guzmán, M. A., Hellings, P. W., Hellquist-Dahl, B., Horak, F., Hourihane, Oʼ B.J., Howarth, P., Humbert, M., Ivancevich, J. C., Jackson, C., Just, J., Kalayci, O., Kaliner, M. A., Kalyoncu, A. F., Keil, T., Keith, P. K., Khayat, G., Kim, Y. Y., Koffi NʼGoran, B., Koppelman, G. H., Kowalski, M. L., Kull, I., Kvedariene, V., Larenas-Linnemann, D., Le, L. T., Lemière, C., Li, J., Lieberman, P., Lipworth, B., Mahboub, B., Makela, M. J., Martin, F., Marshall, G. D., Martinez, F. D., Masjedi, M. R., Maurer, M., Mavale-Manuel, S., Mazon, A., Melen, E., Meltzer, E. O., Mendez, N. H., Merk, H., Mihaltan, F., Mohammad, Y., Morais-Almeida, M., Muraro, A., Nafti, S., Namazova-Baranova, L., Nekam, K., Neou, A., Niggemann, B., Nizankowska-Mogilnicka, E., Nyembue, T. D., Okamoto, Y., Okubo, K., Orru, M. P., Ouedraogo, S., Ozdemir, C., Panzner, P., Pali-Schöll, I., Park, H. S., Pigearias, B., Pohl, W., Popov, T. A., Postma, D. S., Potter, P., Rabe, K. F., Ratomaharo, J., Reitamo, S., Ring, J., Roberts, R., Rogala, B., Romano, A., Roman Rodriguez, M., Rosado-Pinto, J., Rosenwasser, L., Rottem, M., Sanchez-Borges, M., Scadding, G. K., Schmid-Grendelmeier, P., Sheikh, A., Sisul, J. C., Solé, D., Sooronbaev, T., Spicak, V., Spranger, O., Stein, R. T., Stoloff, S. W., Sunyer, J., Szczeklik, A., Todo-Bom, A., Toskala, E., Tremblay, Y., Valenta, R., Valero, A. L., Valeyre, D., Valiulis, A., Valovirta, E., Van Cauwenberge, P., Vandenplas, O., van Weel, C., Vichyanond, P., Viegi, G., Wang, D. Y., Wickman, M., Wöhrl, S., Wright, J., Yawn, B. P., Yiallouros, P. K., Zar, H. J., Zernotti, M. E., Zhong, N., Zidarn, M., and Zuberbier, T.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results